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As myocarjial performance d teriorates, svstemic neuroen- 
docrine reflexes are triggered to maintain cardiac output, 
organ perfusion and circulatory homeostasis. These acti- 
vated rebxes include the alpha-sympathetic nervous ys- 
tem, the renin-angiotensin ystem, vasopressin and atrial 
natriuretic peptide. Locally acting endothelial factors may 
also play a role. Recent studies uggest that he ability of the 
endothelium to qulate vascular tone is altered in heart 
failure. The contribution of this dysfunctional endothehi 
to the vascular rellexes in heart failure is unclear. In addi- 
tion, we have little insight into the mechanisms accounting 
for this endothelial dysfunction. The purpose of this review 
is to present he evidence for endothelial dysfunction i  
heart failure and discuss possible mechanisms. 
Importawe of the Endothelium 
Theelld~modulatesmanyaspectsofvasculer 
homeostasis. These inch& vascular growth, antico@aut 
proper&, perm&lity and vasomotor tone. During the 
pastdecade,muchhasbeenleamedaboutthehnportanceof 
thislatterproperQ.Throughreleaseofparacrineandauto- 
crine substances, the endothelium exerts profound inlhrence 
on the contmctile state of underlying vascular smooth mus- 
cle. The pioneerin work of Purchgott and zawadslci (1) led 
to the idea of a vasorelaxant compound intrinsic to the 
bedkted 
endothelium called endotheliumderived r laxii factor It is 
now known that endotheliumdetived &xii factor is nitxic 
oxide (2) or a closely related compound (3). hIany agents, 
called endothelium-dependent vasod&ors, bind to recep- 
tors on the endothelii surface and stimulate endothelium- 
derived relaxing factor production and rxkase. Such agents 
include bradykinin (4). acetylcholine (l), serotonin (5). 
thrombin and substance P (6). Other endotheliumdependent 
dii stimulate endotheliumktived relaxing factor pro- 
duction and release through nonreceptor media&d pathways 
(for example, the calcium ionophore A23187 [I). In addi- 
tion,bloodflowisapotentstimulusofvasc&rreku&mby 
means of an e&theli~media@d mechanism (8). Once 
stimulated, the endothelii cell produces endothelium- 
derivedrelaxingWorfi-omLarginine(9)usingtheenxyme 
nihic oxide synthase (10). By stimulating cytosolic guanylate 
cyclasewithinthesmoothmusclecell(producinganimTease 
in intracelhllar levels of cyclic ~n=MoWhate 
[ll]),endothelium-derivedrelarringfactorleadsto~d 
vascular smooth muscle. 
The endothe!ium also mediates vasownst&tion. In ex- 
perimental studies (12), endothek thromboxane AZ, super- 
oxideanionandpros~H2havebeenpotentendothe- 
liumderived contract@ &tors. Endothelin-I, aZl-amino 
acid peptide, is the most potent vasoconsukting SUbstanCe 
yet idemiiled (13) and is the only endotheliumderived con- 
tra&gktorknowntobeprodt=dbyhumanendo- 
thelium. Thromboxane Ax (14). prosta%andin I& (IS) and 
superoxide anion (16) have been descrii in rabbit (14). 
hypertensive rat (15) and canine (16) models. In addition, a
poorly~endotheliumderivedcontM&- 
releasedinresponsetohypoxiahasbewdescn’bedinthe 
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lower limb peripheral circuhuion i  humans. Kubo et al. (23) 
measured forearm blood flow during iutraarterial administra- 
tion of the endotheliumdependent dilator methacholine in 14 
patients with heart failure and 14 normal patients. Increases 
in tiow in response tome&choline were signiGcantly de-
pressed inpatients with heart failwe compared with normal 
control patients. In contmst, flow responses to the endoths 
hum-independent ila or nitqxusside were similar in the 
twogroups. These data, like those just descrii, it&ate au 
abnormality of the endothelium in the peripheral microcir- 
culation of patients with heart fake. Patients with ischemic 
and idiopathic dilated cardiomyopathy hadsimilarly hu- 
paired r~qcmses, suggesting that time endothelial abnord- 
ity is not a primary defect. 
Katz et al. @I), using transcutaueous Doppler ultlasollog- 
raphy to determine lower limb arkrial blood tIow velocity, 
i&sed acetylcholhte and nitroglycerin in the femoral rtery 
of 19 patients with heart faihue and 6 -matched control 
patients. Again, patients with heart faihue had no response 
to acetylcholinc i  contrast to normal control patients, 
suggesting an endothelial defect in the peripheral microcir- 
a&ion of tbe human. Endotheliumdependent responses 
were simihuiy impaired te@less of the etiology of heart 
Mure.Responsestoniuoglycerinweuxuildlyimpekdin 
patients with heart failure, suggesting the presence of a 
vascular smooth muscle abmmnahty in addition to alter- 
ations of the endothelial response. However, this 6ndii has 
not been con&med inother studies (21-23). 
Drexleret al. (2!t) studied microvascularresponses in th  
human farearm using high resohuion A-mode and Doppler 
ultrasonography. T ey infused acetylcholine and nitroglyc- 
erininninepatientswithheartfail~andninenormal 
conml patients. Acetylcholine responses were impahed in
patients with heart kihtre, whereas responses to nitroglyc- 
erin were preserved. In addition, it&ion ofthe nitric oxide 
synthaseinhibi@N- nmonomethyl-Ltqinine ptoduced au 
exaegerateddecreaseinbloodfIowiupatientswithheart 





Not all studies have demonstrated impahed responses of 
theendotheliuminheartt5ihtre.Inthecaninemodelof 
. . pacmg-wluccdheartfaihue,Mainetal.(27)foundeuhanced 
endothelhundependent alpha&remxeptor+tK%ted r - 
lax&m in conduit vessels (coroMry artery rhtgs). Ill addi- 
tion, endothehumdependent responses to acetylcholhte 
werenotimpahedinthesevessels. 
In summsry, most studies uggest that eudothelium- 
mediakdrelax&nisatMmakdinreqonsetomuscariuic 





signilicance and etiologic importance of this eudothelial 
defect ate not yet understood. 
Possible Mecbahms of 
Endwm 
The mechanisms of this dy&m&onal endothehal m 
sponse in heart failure are u&town. Possibilk include 
1) alterations i  endothelial ce l surface m or abnor- 
malities ofpostreceptor signal transduction, 2) abmmnahties 
of endothelhuuderived relax.@ tktor production r re- 
lease, 3) rapid inactivation fe&Mhuuderived relax&t 
~~,and4)aaincreaseinendotheliumd~~coneactips 
fhctorproducthmalldactivityinheartfailure.Alterationsin 
vascular smooth muscle r sponsiveness and hupaited ndo- 
theliumderived r laxing factor dilkdon through t e artetU 
intimadouotappeartoplayarole. 
lznd&?MceRsurfuceremluer~.Previous 
studies (30,31) have suggested that atherosckmsis selec- 
tively atkcts endothelial cell surface nxepuxs. This may 
aRobettueinheartfail~(26).Inawronaryli@onmodel 
afheartfailure,Chlthealletal.(26)Mted!8hltikdihUor 
responses to the calcium ionophore A23187 (ammreceptor- 
medhuedendotheliumdependentageut)iathe~a~~ 
OfrstSWithlteartM~dsham-operetedrats.-, 
when both groups were stimulated with acetylcholine, the
dilatorresponsewassig&andyimpairedinratswithheart 
failure, suggesting that he muscatink recepuuouthe~ 
thelial surface (or postreceptor signal tmnsdu&n) is dys- 
fimctional. unforUUe1y, dii ulea!5urements ofrecepuw 
expression r interaction with intracelhdar events have sot 
been made in this model. Without such measuremen& 
implicationsofareceptororasignaltmnsducGondefectin 







zyme nitric oxide synthase (3235). Any peruuMk in this 
endotheliunr-derived elaxb@ factor production process 
CDUld~thGobSelVd-tiSdendothelial 
reSplm&mm in healtfdure. 
NodataexistinanylyeertfaihuemodeltoindictanYstep 
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This enhat& endothelium-a ~n’v~~ 
~sy&esisandreleaseofe&thehmu 
m factor (37,38). Recent data (39) sqggeat that expres- 
~&titIlcoxidesynthasemessengerriboauclec~ 
(~A)andproteinisregulatedbyllow.Itithe~~w 
fbw state twjulting Born myocardisl failure, nitric gxide 




plasma levels d other~neurohumoral agents mecbda- 
. 
n mines, vampressin, m ) on elldowii cell 
hction in heart failure. Fossibly, these agents have s&if- 
il%UltcffitctsOll~~~drelaxingfactorSynthe_ 
sis attd release. Vasopressin may stimulate endothelium- 
medhuedrehU&oninsomevascuhubeds(4O).m%mhuuy 
data (41) sug@st that chronic inhibition of an&ten+ 
convertingenxymetuayhtcreasetheteleaseofortheaction 
ofendotheliunt&rivedreMnglMor.Amoreimpor@nt 
e&t of angiotens~vertinlt enxyme inhibition i volves 






Indirect evidence suggests that ox~nderived free radical 
produ&m is &reased in patients with heart failure (43). 
The oxygenderived free radical super&de is a known 
. . 
macmtord~~nlaxiqe~(44)aad 
cm inhibit clldothclium-- relaxath ill rabbit wro- 
my m3istam vessels (45). Free tddmed&ed inactiva- 
tion of et&Miumderived rehuint) factor in the vascula- 
hue of patients with heart failure could account for 
al&a&msinendothehum=dependentvapodilatiw. 
Additionally,theintlinsicabilityoftheendothelialcellto 
inactivate superoxide radicals may be @aired. Mugee t al. 
(46)havedemanstratedthecritical@oruuKeofthehurin- 
sic flee radical scavenger superoxide ismutase fornormal 
endothe~mediated r laxation. I  the rabbit aorta, un- 
treatedvesselsorvesselstreatedwithacat&sei&bitor 
relax notmally inresponse toacetylcholine. However; in
thosevesselstteatedwithasupe&dedismutaseinhiir, 
acetylcholh~ elicited no sign&am relaxation of rabbit 
sorta, suRgesting that endothelial superoxide ismutase 







served iqahment of endothelium-media&l &xation in 
~~failure~Ybedtedtoanincmsedpresenceof 
~iiUmderiVed COnhCt@ hctors. Endothelin-I, cy- 
~ooxysenaSe producrs @ch~diqj prosta&ndh~ H,, throm- 
boxane A2 and oxygenderived free radicsls) and the endo- 
thehmderivedcon~~producedby hypoxia(12) 
are all candidates. However, only endothelin-1 is known to 
bep&ucedhtandreleasedfromhumancadothelialcells 
(13). This long-a&g, potent vasoconstictor is produced in 
endothelial cells in response to many sthuuli, ncludii 
a@tensin II, ephtephrhie and vasopressht. Endothelin-I 
pN&I&ltiscloselytiedtoemdothelimli4kiivedrelaxisg 
factor and prostacyclin production bymeans of a negative 
feedback mechanism (47). Diminished l vels ofendothelium- 
derivedrelaxiq&torandprostacyclininhuutfailure 
could permit ncreased ndothelin-1 activity. 
Cody et al. (48) demonstrated a threefold &ease in 
plasma endothelht-1 levels in patients with heart failure 
compared with control patients. Stewart et al. (49) have 
obtainedsimihu results. EndothelS levels appear to cor- 
relate with indexes ofheart faihue severity, such as puhno- 
nary capilhtry wedge pressure (50), right atrial presswe (50) 
a d p&onary artery pressure (48). Although most have 
found &teased plasma levels of endothelin-1 in patients 
with stable heart failure (48,49), others have not (51), and the 
pathophysiologif importance of this peptide inheart failure 
remahlsumXrtam 
Products of c;clooxygenese m tabolism (thromboxanc 
A2, prostaglaudin Hz and supcroxide anion) have been 
showntoftmctioaasendotheliumderived coattuctingfactor 
in nonheart failure models (14-16). However, only limited 
data stgtgest the presence of a cyclooxy 
e&thelium-derived wntra&g factor in heart faibue. In 
thecUliflenK%b!lofp&lg-i&cedhegttluihIR,KaiSa 
et al. (22) found that acetylcholine responses were improved 
by the addition of the cyclooxygenase inhibitor indo- 
methacii, suggesting that a cyclooxygenase product is actiq 
as an endotheliumderived contract& factor. The idea that 
a cyclooxygenase product is involved seems reasonable. 
Cyckmxtvt endothelium-derived cant+- 
htgf&torhasbeendescribedinhype&nsion@osm&r& 
Hx) (15)and in the rqenerated endothelium (superoxide 
anion) (52). PreKmuy data (53) suggest the presence of 
a cyclooxygenase endotheliutuderived coatracting &tor 
in hewronarymicrovesselsofpatientswithh~on 
(53). 
In the mid l!Ms, Rubanyi and Vanhoutte (44) noted that 
anoxia/hypoxia elicited endotheliumdependent vascular . 
cwtractrons in the canine vascuhitiue. This nonprostanoid 
ndotheliumderivedcontm&gfitctorhasarapidandtran- 
sient e&t. All attempts to bioassay it have f&d. Whether 
such an endotheliumderived contract& factor could be 
released in the human &c&ion under the hypoxic condi- 
tiOlMOfkU!XCtUhheSltfailurei!3UOtkIWWL 
Angiotensht II has received some attention asa putative 
endothm contr&& l&or (12). Endothelii 
cellshavetheirown&uangiotenshtsystemandtheet& 
thelialcellisthe~or~~~wn~~~ofangiotensinIto 
*>m(5J). We do not know whether local enQthe 
. 
i8ngwlbIIisincreasedinheartfailure 
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to concentrations sufficient to directly constrict underlying 
vascular smooth muscle. 
coiM!luBlonB 
in patients with heart failure, microvascular relaxation is
impaued in response to endothelimndepeudent vasodila- 
tots. We currently have !ittle understanding of the mecha- 
nisms accounthtg for this dysfunctional state of the endothe- 
lium. Multiple steps in endotheliumderived r laxing factor 
production and release may be a&ted. Additioually, one or 
more endotheliumderived contracting tbctors could assume 
more importance in heart Ehtre. 
Research directed at a better understanding of the mech- 
anisms of endothelial dysfunction i heart faihue is needed. 
Understanding the effects of low flow states on the regula- 
tion of endotheliumderived r laxing factor production, the 
role of oxygen-derived free radicals and the presence ofand 
role of endotheliumderived contracting factors will provide 
insights for understanding the abnormalities of vascular 
homeostasis in heart failure. Therapy tailored from a knowl- 
edge ofdysRtuctional mechanisms will be increasingly et&c- 
tive in the treatment and prevention ofheart failure. 
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